Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Arthritis Research & Therapy|August 19, 2009
Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitisDésirée M van der Heijde, Dennis A Revicki, Katherine L Gooch, et al.
Journal of Market Access & Health Policy|June 1, 2023
Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United StatesAlexa C Klimchak, Lauren E Sedita, Louise R Rodino-Klapac, et al.
Annals of Hepatology|August 11, 2015
Liver-specific case fatality due to chronic hepatitis C virus infection: a systematic reviewShelagh M Szabo, Jennifer C Samp, David R Walker, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|February 6, 2013
Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxisXavier Carbonell-Estrany, John R Fullarton, Katherine L Gooch, et al.
Pharmacoeconomics - Open|April 16, 2020
Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive BladderGreta Lozano-Ortega, Carol R Schermer, David R Walker, et al.
American Journal of Physiology. Cell Physiology|December 17, 2013
miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated exportMatthew B Hudson, Myra E Woodworth-Hobbs, Bin Zheng, et al.
Neurobiology of Disease|April 15, 2020
Formoterol, a β<sub>2</sub>-adrenoreceptor agonist, induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injuryHemendra J Vekaria, W Brad Hubbard, Natalie E Scholpa, et al.
Advances in Therapy|July 13, 2026
Estimating Utility Values Using the DMD-QoL: A Disease-Specific Preference-Based Measure for Duchenne Muscular Dystrophy (DMD)Andrea Bever, Shelagh M Szabo, Pramoda Jayasinghe, et al.
Journal of Patient-Reported Outcomes|December 15, 2023
Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5LIvana F Audhya, Shelagh M Szabo, Andrea Bever, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 12, 2016
The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysisXavier Carbonell-Estrany, John R Fullarton, Katherine L Gooch, et al.
Pageof 15